Dr. Holick is Professor of Medicine and Physiology at Boston University School of Medicine and Chief of Endocrinology, Metabolism, and Nutrition. Since 1987, he has been the Program Director of the General Clinical Research Center at the School of Medicine. He has extensive experience on national review committees and study sections and in reviewing research applications.

After earning a PhD in biochemistry and a medical degree, and after completing a research postdoctoral fellowship at the University of Wisconsin, Madison with Dr. Hector DeLuca, Dr. Holick completed his residency in medicine at the Massachusetts General Hospital in Boston.

Dr. Holick has served on a number of national committees and editorial boards and has organized and/or co-chaired several international symposia. He has authored more than 230 peer-reviewed publications and written more than 200 review articles as well as numerous book chapters. He has acted as editor and/or co-editor on 8 books, and has recently written a book entitled The UV Advantage. He is also the recipient of the GCRC 2006 Excellence in Clinical Research Award.

William Ehringer, Ph.D.

Dr. Ehringer is the inventor of the VitaSol a unique liposomal technology that directly delivers energy in the form of adenosine triphosphate (ATP) to the cells Dr. Ehringer is Founder and Chief Scientific Officer of VitaTech; Associate Professor, Department of Physiology and Biophysics at the University of Louisville; and Director, Center for Cellular Energy Delivery, University of Louisville School of Medicine.

Harold Lazar, M.D.

Dr. Lazar is director of Cardiothoracic Surgical Research and an attending cardiothoracic surgeon at Boston Medical Center (BMC), and a professor of cardiothoracic surgery at the Boston University School of Medicine. Dr. Lazar has published nearly 200 articles, book chapters and abstracts and has received numerous professional awards.

He graduated from Boston University School of Medicine in 1974 and completed residencies at University Hospital at the University of Michigan and Columbia-Presbyterian Medical Center.

Dr. Lazar serves on the editorial boards for The Journal of Thoracic and Cardiovascular Surgery, and Cardiology Review, and was the editor of the book, Current Therapy for Acute Coronary Ischemia. He currently serves as president of the Society of Coronary Sinus Interventions and is past president of the Massachusetts Consortium for Lung Transplantation. Dr. Lazar is also the inventor of the “GIK” cardioplegic solution.